Dr. John W. Finnie, MD

Expert Publications

• Neuronal damage produced in rat brains by Clostridium perfringens type D epsilon toxin.
• Multifocal cerebellar granular layer necrosis in traumatically head-injured lambs.
• Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: an ovine head impact model.
• Alpha-mannosidosis in the guinea pig: a new animal model for lysosomal storage disorders.
• Upregulation of neuronal amyloid precursor protein (APP) and APP mRNA following magnesium sulphate (MgSO4) therapy in traumatic brain injury.
• Axonal and neuronal amyloid precursor protein immunoreactivity in the brains of guinea pigs given tunicamycin.
• Effect of impact on different regions of the head of lambs.
• Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood-brain barrier (BBB).
• Toxin-induced vasogenic cerebral oedema in a rat model.
• Effect of tunicamycin on hepatocytes in vitro.
• Long-term exposure of E-mu-Pim1 transgenic mice to 898.4 MHz microwaves does not increase lymphoma incidence.
• Brain damage in sheep from penetrating captive bolt stunning.
• Effect of long-term mobile communication microwave exposure on vascular permeability in mouse brain.
• The biologic response to particles from a lumbar disc prosthesis.
• Traumatic brain injury.

Media Releases

Get to know Hematologist-Oncologist Dr. John W. Finnie, who serves patients in St. Louis, Missouri.

A board-certified hematologist-oncologist, Dr. Finnie practices at Mercy Clinic Oncology and Hematology – David C. Pratt Cancer Center in St. Louis, Missouri. He provides care for patients with all cancer diagnoses, with bleeding disorders, anemia, and with “hypercoagulable states” which means tendency for excessive blood clot development.

The Mercy Clinic Oncology and Hematology at the David C. Pratt Cancer Center is committed to patients and their fight against cancer. Their goal is to make this journey as fast and successful as they know how. Patients will benefit from their rapid, ongoing advances in the diagnosis and treatment of cancer.

Pertaining to his educational pursuits, Dr. Finnie earned his medical degree and completed his residency in internal medicine at Saint Louis University. He then went on to complete his fellowship in oncology at the University of Kentucky – Albert B. Chandler Hospital.

Dedicated to clinical excellence, the doctor is board-certified in hematology, medical oncology and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Holding a license to practice medicine in Missouri, Dr. Finnie can be found on staff at Mercy Hospital St. Louis, and Mercy Hospital Washington.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

Recognized as a Top Doctor by Castle Connolly Magazine, Dr. Finnie has been the recipient of the Top Doctor Award by Missouri Life Magazine in 2021.

On a more personal note, he is fluent in both English and German.

Recommended Articles

• Stanford University's Linebacker Ryan Beecher Must Now Tackle Lymphoma

  There's no doubt that Ryan Beecher is strong. If you want just watch one Stanford University football game, you'll see that and then some. However, he is now going to have to use a different type of strength in his battle against lymphoma.Ryan's storyWhile many had been following Ryan Beecher before...

• Seven-year-old Lymphoma Ninja Warrior Fights Through 500 Days of Chemo

  In some ways, Von Kleiv is an ordinary 7-year-old boy. He goes to Welch Elementary School in Dover, Delaware. He’s in second grade. He’s getting into karate, and just broke his first wooden board at his first demonstration. People know him as a boy warrior with a strong spirit. He is optimistic,...

• How This Survivor Star Beat Hodgkin Lymphoma—Twice

  Ethan Zohn is a survivor in many ways. In 2002, he outlasted 15 fiercely strong competitors on the popular TV show, Survivor: Africa. His strength, wit, athleticism, and perseverance won him a million-dollar prize after he defeated these opponents. However, his victory was short-lived. Little did he...

• Promising Results for Hodgkin Patients Using This Therapy

  Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...

• Morphos Declared a "Breakthrough Therapy" for Lymphoma

  MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...

• Teen with Hodgkin Lymphoma Skates with Her Hero, Mario Lemieux

  Lillian Tarasiewicz was diagnosed with stage 3B Hodgkin lymphoma in October of 2015. She currently resides in South Carolina, but because of her father’s Pennsylvania background, she grew up with a love for hockey and for the Pittsburgh Penguins. She always felt a special connection to Mario...